Cargando…
COVID-19 and Phosphodiesterase Enzyme Type 5 Inhibitors
COVID-19 pathology is mainly associated to a pulmonary disease which sometimes might result in an uncontrollable storm related to inflammatory diseases which could be fatal. It is well known that phosphodiesterase enzyme type 5 inhibitors (PDE5Is), such as sildenafil, have been successfully develope...
Autores principales: | Al-Kuraishy, Hayder M., Al-Gareeb, Ali I., Al-Niemi, Marwa S., Al-Buhadily, Ali K., Al-Harchan, Nasser A., Lugnier, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883493/ https://www.ncbi.nlm.nih.gov/pubmed/33623736 http://dx.doi.org/10.4103/JMAU.JMAU_63_20 |
Ejemplares similares
-
Rosuvastatin as forthcoming antibiotic or as adjuvant additive agent: In vitro novel antibacterial study
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2018) -
New insight into the effect of lycopene on the oxidative stress in acute kidney injury
por: Rasheed, Huda A., et al.
Publicado: (2020) -
The Potential Role of Pancreatic γ-Aminobutyric Acid (GABA) in Diabetes Mellitus: A Critical Reappraisal
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2021) -
Impact of thioctic acid on glycemic indices and associated inflammatory-induced endothelial dysfunction in patients with type 2 diabetes mellitus: A case control study
por: Al-Nami, Marwa S., et al.
Publicado: (2020) -
Citicoline and COVID-19: vis-à-vis conjectured
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)